BLISTEX ULTRA Lip Balm
SPF 50+, broad spectrum, stick, lip. AUST L 427682, from Key Pharmaceuticals Pty Ltd.
Keep using sunscreen. The TGA says its benefits far outweigh any risks, and nothing here says a product is unsafe: the limits are proposals.
Active ingredients
| Ingredient | On the ARTG as | Amount | % |
|---|---|---|---|
| Octinoxate | octyl methoxycinnamate | 100 mg/g | 10% |
| DHHB | diethylamino hydroxybenzoyl hexyl benzoate | 50 mg/g | 5% |
| Octisalate | octyl salicylate | 50 mg/g | 5% |
| Avobenzone | butyl methoxydibenzoylmethane | 25 mg/g | 2.5% |
| Bemotrizinol | bemotrizinol | 10 mg/g | 1% |
Percent by weight: the ARTG gives each active in mg per gram, and 10 mg/g is 1%.
Against the TGA’s proposed limits
This sunscreen lists none of the three filters under review (homosalate, oxybenzone and 4-MBC), so none of the proposed limits would apply to it.
Where this comes from
Everything above is from this product’s entry on the Australian Register of Therapeutic Goods: ARTG 427682, BLISTEX ULTRA Lip Balm. We read its public summary on 21 October 2026; the entry dates from 10 November 2023. The name on the shelf can differ from the register’s. If the label shows a different AUST L number, it’s a different formula. Spotted a mistake? Email hello@sunscreenfilters.com.
Worried about an ingredient, or choosing for a baby or someone with sensitive skin? Talk to your doctor or pharmacist.
More from Blistex
- Blistex Five Way Lip Protection (reformulation) Homosalate 10%, Octinoxate 7.5%, Octisalate 5%, Avobenzone 3% Homosalate 10%, above all three TGA proposed limits
- Blistex Lip Conditioner Homosalate 10%, Avobenzone 5%, Octisalate 5%, Bemotrizinol 3% Homosalate 10%, above all three TGA proposed limits
- Blistex Lip Conditioning Balm Homosalate 10%, Avobenzone 5%, Octisalate 5%, Bemotrizinol 3% Homosalate 10%, above all three TGA proposed limits
- Blistex Ultra Lip Balm Octinoxate 3%, Avobenzone 2.5%, DHHB 2.4%, Bemotrizinol 1%, Oxybenzone 1% Oxybenzone 1%, within options 1 and 2